Guman Duan

Dr. Guman Duan

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in World Neurosurgery
Verified
Journal Article
Closed access
WLWeiwei Lin
Weiwei Lin
GDGuman Duan
Guman Duan
JXJinjin Xie
Jinjin Xie
JSJiashen Shao
Jiashen Shao
ZWZhaoqi Wang
Zhaoqi Wang
BJBaohua Jiao
Baohua Jiao

1 June 2018 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
GDGuman Duan
Guman Duan
CLChang Liu
Chang Liu
WLWeiwei Lin
Weiwei Lin
JSJiashen Shao
Jiashen Shao
KFKunpeng Fu
Kunpeng Fu
FWFei Wang
Fei Wang

1 June 2018 in The Bone & Joint Journal
Verified
Journal Article
Closed access
KFK. Fu
K. Fu
GDGuman Duan
Guman Duan
CLC. Liu
C. Liu
Jinan NiuJinan Niu
Jinan Niu
FWF. Wang
F. Wang
Aims: The aim of this study was to investigate the changes in femoral trochlear morphology following surgical correction of recurrent patellar dislocation associated with trochlear dysplasia in children.Patients and Methods: A total of 23 patients with a mean age of 9.6 years (7 to 11) were included All had bilateral recurrent patellar dislocation associated with femoral trochlear dysplasia. The knee with traumatic dislocation at the time of presentation or that had dislocated most frequently was treated with medial patellar retinacular plasty (Group S). The contralateral knee served as a control and was treated conservatively (Group C). All patients were treated between October 2008 and August 2013. The mean follow-up was 48.7 months (43 to 56). Axial CT scans were undertaken in all patients to assess the trochlear morphological characteristics on a particular axial image which was established at the point with the greatest epicondylar width based on measurements preoperatively and at the final follow-up.Results: Preoperatively, there were no statistically significant differences between the trochlear morphology in the two groups (sulcus angle, p 0.852; trochlear groove depth, p 0.885; lateral trochlear inclination, p 0.676; lateral-to-medial facet ratio, p 0.468; lateral condylar height, p 0.899; medial condylar height, p 0.816). Many radiological parameters of trochlear morphology were significantly different between the two groups at the final follow-up, including well-known parameters, such as the mean sulcus angle (Group S, 146.27° (sd 7.18); Group C, 160.61° (sd 9.29); p < 0.001), the mean trochlear groove depth (Group S, 6.25 mm (sd 0.41); Group C, 3.48 mm (sd 0.65); p < 0.001) and the mean lateral trochlear inclination (Group S, 20.99° (sd 3.87); Group C, 12.18° (sd 1.85); p < 0.001). Lesser known parameters such as the ratio of the lateral to medial trochlear length (Group S, 1.46 (sd 0.19); Group C, 2.14 (sd 0.42); p < 0.001), which is a measurement of facet asymmetry, and the lateral and medial condylar height were also significantly different between the two groups (p < 0.001).Conclusion: The femoral trochlear morphology can be improved by early (before epiphyseal closure) surgical correction in children with recurrent patellar dislocation associated with femoral trochlear dysplasia. Cite this article: Bone Joint J 2018;100-B:811–21.

31 October 2022 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
GDGuman Duan
Guman Duan
CLChengli Li
Chengli Li
XYXiaoqing Yan
Xiaoqing Yan
SYShuhui Yang
Shuhui Yang
SWShuo Wang
Shuo Wang
XWXiumei Wang
Xiumei Wang
A new nerve guidance conduits named MC@Col containing type I collagen and mineralized collagen (MC) was developed, enhancing mechanical and degradation behavior. The physicochemical properties, the mechanical properties, and in vitro degradation behavior were all evaluated. The adhesion and proliferation of Schwann cells (SCs) were observed. In the in vivo experiment, MC@Col NGC and other conduits including collagen (Col), chitosan (CST) and polycaprolactone (PCL) conduit were implanted to repair a 10-mm-long Sprague-Dawley rats sciatic nerve defect. Histological analyses, morphological analyses, electrophysiological analyses, and further gait analyses were all evaluated after implantation in 12 weeks. The strength and degradation performance of the MC@Col NGC were improved by the addition of MC in comparison with pure collagen NGC. In vitro cytocompatibility evaluation revealed that the Schwann cells (SCs) had good viability, attachment, and proliferation in the MC@Col. In In vivo results, the regenerative outcomes of MC@Col NGC were close to those by an autologous nerve graft in some respects, but superior to those by Col, CST and PCL conduits. The MC@Col NGC exhibited good mechanical performance as well as biocompatibility to bridge nerve gap and guide nerve regeneration, thus showing great promising potential as a new type of conduit in clinical applications.

14 November 2017 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
CLChang Liu
Chang Liu
GDGuman Duan
Guman Duan
YNYingzhen Niu
Yingzhen Niu
PCPengkai Cao
Pengkai Cao
KFKunpeng Fu
Kunpeng Fu
FWFei Wang
Fei Wang

12 March 2018 in Neurological Research
Verified
Journal Article
Closed access
WLWeiwei Lin
Weiwei Lin
HXHongtao Xu
Hongtao Xu
GDGuman Duan
Guman Duan
JXJinjin Xie
Jinjin Xie
YCYisheng Chen
Yisheng Chen
HLHaitao Lan
Haitao Lan
Purpose Tethered cord syndrome (TCS) is the clinical manifestation of an abnormal stretch on the spinal cord, caused by several pathological conditions. Tethered cord release is the gold standard treatment for TCS. However, direct untethering carries potential risks of spinal cord injury, post-operative retethering, and CSF-related complications. Spine-shortening osteotomy (SSO) has recently been performed as an alternative technique to avoid these risks. We aimed to systematically review the literature on indications and outcome of SSO in TCS patients. Methods We searched PubMed, Embase, Google Scholar, and the Cochrane Library to identify all studies on SSO in TCS patients. We used random or fixed-effects models to calculate rates and 95% confidence intervals to establish the rates of clinical improvement in TCS patients performed with SSO. Sensitive analysis and metaregression were made to explore potential sources of heterogeneit. Results We identified six eligible surveys with a total population of 57. Rates ranged from 62 to 88% for neurological deficits improvement, 80-100% for motor function improvement, 60-96% for pain or numbness scores improvement, 13-67% for sensory function improvement, and 79-100% for urinary and bowel dysfunction improvement. We noted substantial heterogeneity in rate estimates for motor function and urinary and bowel dysfunction improvement (all Cochran's χ² significant at P < 0.001; I² = 78.11%, 95%CI 61-94%; 84.28%, 18-100%; respectively). Conclusion SSO is a safe and effective technique for TCS patients, especially in more challenging cases, such as complex malformations or revision surgery. However, future cohort studies and randomized studies with large numbers and the power to provide illumination for the surgical decision-making of TCS are warranted.